Poster #100 SEVERE TRAUMA AND FIRST EPISODE PSYCHOSIS IN THE UK

2012 ◽  
Vol 136 ◽  
pp. S221
Author(s):  
Adanna N. Onvejiaka ◽  
Helen Fisher ◽  
Charlotte E. Gayer-Anderson ◽  
Anisa Kurti ◽  
Susana Borges ◽  
...  
Keyword(s):  
Severe Trauma ◽  
First Episode Psychosis ◽  
First Episode ◽  
Episode Psychosis ◽  
The Uk

First episode psychosis patients show impaired cognitive function – a study of a South Asian population in the UK

2013 ◽  
Vol 27 (4) ◽  
pp. 366-373 ◽  
Author(s):  
Majid M Saleem ◽  
Michael K Harte ◽  
Kay M Marshall ◽  
Andy Scally ◽  
Anita Brewin ◽  
...  
Keyword(s):  
Cognitive Function ◽  
South Asian ◽  
Asian Population ◽  
First Episode Psychosis ◽  
First Episode ◽  
South Asian Population ◽  
Impaired Cognitive Function ◽  
Episode Psychosis ◽  
The Uk

scholarly journals Patients with First Episode Psychosis Take More and Stronger Cannabis than Controls

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
M. Di Forti
Keyword(s):  
Employment Status ◽  
Epidemiological Studies ◽  
First Episode Psychosis ◽  
First Episode ◽  
Active Constituent ◽  
Level Of Education ◽  
Increased Risk ◽  
Episode Psychosis ◽  
Education And Employment ◽  
The Uk

Epidemiological studies have reported that the increased risk of developing psychosis in cannabis users is dose related. In addition, experimental research has shown that the active constituent of cannabis responsible for its psychotogenic effect is Delta-9-Tetrahydrocannabinol (THC) (Murray et al, 2007). Recent evidence has suggested an increased in potency (% TCH) in the cannabis seized in the UK (Potter et al, 2007). We predicted that first episode psychosis patients are more likely to use higher potency cannabis and more frequently than controls.We collected information concerning socio-demographic, clinical characteristics and cannabis use (age at first use, frequency, length of use, type of cannabis used) from a sample of 191 first-episode psychosis patients and 120 matched healthy volunteers. Cases were more likely to be regular users (p=0.05), to be current users (p=0.04) and to have smoked cannabis for longer (p=0.01). Among cannabis users, 86.8% of 1st Episode Psychosis Patients preferentially used Skunk/Sinsemilla compared to 27.7% of Controls. Only 13.2 % of 1st Episode psychosis Patients chose to use Resin/Hash compared to 76.3% of controls (OR*= 7.4 95% CI 3.4- 17.2, Adjusted for age, gender, ethnicity, level of Education and employment status).The concentration of TCH in these in South East London, ranges between 8.5 and 14 % (Potter et al, 2007). Controls (47%) were more likely to use Hash (Resin) whose average TCH concentration is 3.4% (Potter et al, 2007).Patients with first episode psychosis have smoked higher potency cannabis, for longer and with greater frequency, than healthy controls.

Satisfaction with inpatient treatment for first-episode psychosis among different ethnic groups: A report from the UK ÆSOP study

2010 ◽  
Vol 58 (1) ◽  
pp. 98-105 ◽  
Author(s):  
Jane Boydell ◽  
Craig Morgan ◽  
Rina Dutta ◽  
Barry Jones ◽  
Fana Alemseged ◽  
...  
Keyword(s):  
Ethnic Groups ◽  
Inpatient Treatment ◽  
First Episode Psychosis ◽  
First Episode ◽  
Episode Psychosis ◽  
The Uk

The impact of manic symptoms in first‐episode psychosis: findings from the UK National EDEN study

2021 ◽  
Author(s):  
Steven Marwaha ◽  
Danielle Hett ◽  
Sonia Johnson ◽  
David Fowler ◽  
Joanne Hodgekins ◽  
...  
Keyword(s):  
First Episode Psychosis ◽  
First Episode ◽  
Manic Symptoms ◽  
Episode Psychosis ◽  
The Uk ◽  
The Impact

Skunk and psychosis in South East London

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
M. Di Forti ◽  
C. Morgan ◽  
V. Mondelli ◽  
L. Gittens ◽  
R. Handley ◽  
...  
Keyword(s):  
Life Time ◽  
Epidemiological Studies ◽  
First Episode Psychosis ◽  
Cannabis Use ◽  
First Episode ◽  
Active Constituent ◽  
Increased Risk ◽  
Episode Psychosis ◽  
Significant Difference ◽  
The Uk

Background:Epidemiological studies have reported that the increased risk of developing psychosis in cannabis users is dose related. In addition, experimental research has shown that the active constituent of cannabis responsible for its psychotogenic effect is Delta-9-Tetrahydrocannabinol (THC) (Murray et al, 2007). Recent evidence has suggested an increased in potency (% TCH) in the cannabis seized in the UK (Potter et al, 2007).Hypothesis:We predicted that first episode psychosis patients are more likely to use higher potency cannabis and more frequently than controls.Methods:We collected information concerning socio-demographic, clinical characteristics and cannabis use (age at first use, frequency, length of use, type of cannabis used) from a sample of 191 first-episode psychosis patients and 120 matched healthy volunteers. All were recruited as part of the Genetic and Psychosis (GAP) study which studied all patients who presented to the South London and Maudsley Trust.Results:There was no significant difference in the life-time prevalence of cannabis use or age at first use between cases and controls. However, cases were more likely to be regular users (p=0.05), to be current users (p=0.04) and to have smoked cannabis for longer (p=0.01). Among cannabis users, 86.8% of 1st Episode Psychosis Patients preferentially used Skunk/Sinsemilla compared to 27.7% of Controls. Only 13.2 % of 1st Episode psychosis Patients chose to use Resin/Hash compared to 76.3% of controls. The concentration of TCH in these in South East London, ranges between 8.5 and 14 % (Potter et al, 2007). Controls (47%) were more likely to use Hash (Resin) whose average TCH concentration is 3.4% (Potter et al, 2007).Conclusions:Patients with first episode psychosis have smoked higher potency cannabis, for longer and with greater frequency, than healthy controls.

scholarly journals A comparison of the nutrient intake of a community-dwelling first-episode psychosis cohort, aged 19–64 years, with data from the UK population

2015 ◽  
Vol 4 ◽  
Author(s):  
Kevin Williamson ◽  
Karen Kilner ◽  
Nicola Clibbens
Keyword(s):  
Mental Health ◽  
Dietary Habits ◽  
National Sample ◽  
First Episode Psychosis ◽  
Community Dwelling ◽  
First Episode ◽  
Study Cohort ◽  
Nutrient Intakes ◽  
Episode Psychosis ◽  
The Uk

AbstractPsychosis increases the risk of CVD, obesity and type 2 diabetes and reduces life expectancy. There are limited data comparing the dietary habits of community-dwelling first-episode psychosis sufferers – with autonomy over diet – and the general population. The data represent the retrospective evaluation of nutritional data collected between 2007 and 2013 from 143 individuals from the UK population receiving treatment for first-episode psychosis. Differences in mean nutrient intakes between the study cohort and the national sample were tested for statistical significance using independent t tests, incorporating Satterthwaite's correction where required. Mean total energy intake was lower for males (P = 0·049) and higher for females (P = 0·016) in the cohort than in the corresponding subgroups of the national sample. Females in the study cohort consumed 12·9 (95 % CI 4·3, 21·5) g more total fat per d, whilst males consumed 7·7 (95 % CI 0·5, 14·9) g less protein per d than the national sample. Males in the study also showed significantly lower mean intakes than nationally of folate, Fe, Se, vitamin D and Zn, but not vitamin C. The proportion of individuals not meeting the lower reference nutrient intakes, particularly for Se (males 54·0 % and females 57·1 %) and for Fe amongst females (29·6 %), is cause for concern regarding potentially severe deficiencies. Further exploration of dietary habits within first-episode psychosis is warranted to assess whether individuals make beneficial dietary changes for their physical and mental health and wellbeing following dietary change intervention. It would also be pertinent to assess any correlation between diet and mental health symptomology.

Sign in / Sign up

Export Citation Format

Share Document